Marc Lippman's Contact Details
- Company
- Ascenta Therapeutics
- Company Address
- Malvern PA
About Marc Lippman
Marc Lippman - Dr. Lippman is one of the world's leading authorities in the field of breast cancer. Until May of 2007, he was the John G. Searle Professor and Chair, Department of Internal Medicine at the University of Michigan. He was previously the Director of the Lombardi Cancer Research Center, Professor and Chairman of the Department of Oncology, and Professor of Medicine at Georgetown University Medical School. He was also Chief of the Division of Hematology-Oncology. Prior to his appointment at Georgetown, he was Head of the Medical Breast Cancer Section of the Medicine Branch of the National Cancer Institute. He received his B.A., magna cum laude from Cornell (1964) and his M.D. from Yale where he was elected to Alpha Omega Alpha (1968). He completed internship and residency in internal medicine at Johns Hopkins Hospital on the Osler Service and further fellowship training at the National Cancer Institute where he remained until 1988 when he went to Georgetown University. Dr. Lippman has attempted to bridge the gap between basic tumor biology and clinical application in the field of breast cancer. His work established the critical role of growth factors in human breast cancer and in an extensive series of studies has characterized and purified these factors and designed antitumor therapies based on these insights. He has received the Clinical Investigator Prize of the American Federation for Clinical Research, the Rosenthal Award of the AACR, the American Cancer Society Lectureship awarded by ASCO, the Astwood Prize of the Endocrine Society, and the Brinker International Prize for Basic Research in Breast Cancer. He has authored over 500 publications and one of the standard texts on breast cancer, and has successfully pursued clinical trials for every stage of breast cancer. Dr. Lippman has extensive experience in business development in biotechnology. With sponsorship from Health Care Ventures, he was a cofounder of Oncologix, a diagnostics company successfully sold to Aronex. Subsequently, he co-founded Peregrine Biotechnology which was successfully sold to Techniclone. He is a senior managing director for Perseus, LLC.
Marc Lippman's Current Workplace
- Headquarters
- 101 Lindenwood Drive, Suite 405, Suite 405, Malvern PA
- Website
- ascenta.com
- Revenue
- 50000
- Employees
- 249
- Industry
- Major Drugs